You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hemoglobinopathies

Showing 26 - 50 of 138
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sickle Cell Disease, Thalassemia Major Trial in Philadelphia (CliniMACS)

Recruiting
  • Sickle Cell Disease
  • Thalassemia Major
  • CliniMACS
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Dec 22, 2021

Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell

Completed
  • Hematologic Malignancies
  • +7 more
  • San Francisco, California
    University of California, San Francisco
Sep 27, 2021

Fludarabine Drug Exposure in Pediatric Bone Marrow

Completed
  • Hematologic Malignancies
  • +7 more
  • San Francisco, California
    University of California, San Francisco
Sep 27, 2021

Clofarabine and Fludarabine Drug Exposure in Pediatric Bone

Completed
  • Hematologic Malignancies
  • +7 more
  • San Francisco, California
    University of California, San Francisco
Sep 27, 2021

A Long-term Follow-up Study in Subjects Who Received CTX001

Enrolling by invitation
  • Beta-Thalassemia
  • +6 more
  • CTX001
  • New York, New York
  • +12 more
Nov 18, 2022

Hemoglobinopathy (Disorder), Severe Aplastic Anemia, Bone Marrow Failure Syndrome Trial in Saint Petersburg (Haploidentical

Recruiting
  • Hemoglobinopathy (Disorder)
  • +2 more
  • Haploidentical Hematopoietic Cell Transplantation
  • Saint Petersburg, Florida
    Johns Hopkins All Children's Hospital
Sep 13, 2022

Hematologic Disorders, Hemoglobinopathies, Immunodeficiencies Trial in Minneapolis (drug, radiation, biological)

Recruiting
  • Hematologic Disorders
  • +2 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Jul 12, 2021

Sickle Cell Disease, Hemoglobinopathies Trial in Canada, United States (EDIT-301)

Recruiting
  • Sickle Cell Disease
  • Hemoglobinopathies
  • EDIT-301
  • Oakland, California
  • +18 more
Jan 10, 2023

Haematological Malignancy, Acute Leukemia, MDS Trial in Lyon (Physical activity program)

Not yet recruiting
  • Haematological Malignancy
  • +5 more
  • Physical activity program
  • Lyon, France
    Institut d'Hématologie et d'Oncologie Pédiatrique
Mar 25, 2022

Haematological Malignancy, Acute Leukemia, MDS Trial in Lyon (Physical activity program)

Withdrawn
  • Haematological Malignancy
  • +5 more
  • Physical activity program
  • Lyon, France
    Institut d'Hématologie et d'Oncologie Pédiatrique
Feb 10, 2022

Sickle Cell Disease Trial in Louisville, Durham, Pittsburgh (Enriched Hematopoetic Stem Cell Infusion)

Completed
  • Sickle Cell Disease
  • Enriched Hematopoetic Stem Cell Infusion
  • Louisville, Kentucky
  • +2 more
Oct 6, 2020

Sickle Cell Disease, Hemoglobin SC Trial in Houston (Busulfan, Campath 1H, Cyclophosphamide and MESNA)

Terminated
Has Results
  • Sickle Cell Disease
  • Hemoglobin SC
  • Houston, Texas
  • +1 more
Jul 16, 2020

Sickle Cell Anemia, Sickle Cell Disease, Hemoglobin Disorder Trial in Houston (Metformin, Questionnaires)

Completed
  • Sickle Cell Anemia
  • +2 more
  • Houston, Texas
  • +1 more
Nov 9, 2020

Beta-Thalassemia Trial in Ferrara, Firenze, Pisa (Sirolimus 0.5 mg)

Recruiting
  • Beta-Thalassemia
  • Sirolimus 0.5 mg
  • Ferrara, FE, Italy
  • +3 more
Nov 11, 2021

Metabolic Disorders, Hematologic, Immune, or Bone Marrow Disorders, Hemoglobinopathies Trial in Canada, United States (Treatment

Recruiting
  • Metabolic Disorders
  • +3 more
  • Treatment Plan 1: Stratum 1
  • +3 more
  • Phoenix, Arizona
  • +19 more
Oct 12, 2021

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (CD34+ enriched, T Cell

No longer available
  • Acute Lymphoblastic Leukemia
  • +11 more
  • CD34+ enriched, T Cell Depleted donor stem cell product
  • San Francisco, California
    University of California, San Francisco
May 25, 2021

Sickle Cell Anemia, Hemoglobinopathy, Thalassemia Trial in Houston (Campath -1H, Dilantin, Busulfan)

Terminated
  • Sickle Cell Anemia
  • +2 more
  • Campath -1H
  • +3 more
  • Houston, Texas
  • +1 more
Jan 15, 2020

Sickle Cell Anemia, Hemoglobinopathy, Thalassemia Trial in Houston (FLUDARABINE, CAMPATH-IH, Total Body Irradiation)

Terminated
  • Sickle Cell Anemia
  • +2 more
  • Houston, Texas
  • +1 more
Jan 15, 2020

Primary Immunodeficiencies, Inborn Errors of Metabolism, Haemoglobinopathies Trial in Worldwide (Treosulfan, Busilvex)

Active, not recruiting
  • Primary Immunodeficiencies
  • +3 more
  • Prague, Czechia
  • +20 more
Apr 19, 2022

Bone Marrow Failure Syndrome, Severe Aplastic Anemia, Severe Congenital Neutropenia Trial in New York (CD34 Stem Cell Selection

Active, not recruiting
  • Bone Marrow Failure Syndrome
  • +15 more
  • CD34 Stem Cell Selection Therapy
  • New York, New York
    Morgan Stanley Children's Hospital, New York-Presbyterian, Colum
Jun 17, 2020

Bone Marrow for Hemoglobinopathy Research

Completed
  • Sickle Cell Anemia
  • Thalassemia
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Feb 21, 2020

    Pediatric Cancer, Immune System Disorder, COVID-19 Trial in United States

    Unknown status
    • Pediatric Cancer
    • +3 more
      • Hartford, Connecticut
      • +16 more
      Jun 22, 2020

      Multi-Center Study of Iron Overload: Survey Study (MCSIO)

      Completed
      • Sickle Cell Disease
      • +2 more
        • Oakland, California
        • +7 more
        Sep 22, 2020

        Chronic Iron Overload Trial in Worldwide (Deferiprone, Deferasirox)

        Completed
        Has Results
        • Chronic Iron Overload
        • Lushnjë, Albania
        • +21 more
        Apr 8, 2021

        Sickle Cell Disease, Thalassemia Trial in Oakland, Washington, Paris (CordIn)

        Terminated
        Has Results
        • Sickle Cell Disease
        • Thalassemia
        • CordIn
        • Oakland, California
        • +2 more
        Jun 3, 2019